Genetic or pharmacological inhibition of AURKA significantly inhibited GSK3β S9 phosphorylation in pancreatic cancer cells, suggesting that GSK3β might indeed act as a downstream target of AURKA in necroptosis. This evidence concerns the gene GSK3B and familial pancreatic carcinoma.